NCT00958516View on ClinicalTrials.gov

Assessment of the Phototoxic Potential of LEO 29102 Cream

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Atopic Dermatitis

Interventions

DRUG

LEO 29102 cream

LEO 29102 cream in different doses and the cream vehicle

Trial Locations (1)

78054

LEO Pharma investigational site, Saint-Quentin-en-Yvelines

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY